Similar articles

• The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.

  Dixit S, Hingorani M, Achawal S, Scott I. Dixit S, et al. Br J Neurosurg. 2011 Aug;25(4):459-69. doi: 10.3109/02688697.2010.550342. Epub 2011 Feb 23. Br J Neurosurg. 2011. PMID: 21344976 Review.
• Management of glioblastoma.

  Aoki T, Hashimoto N, Matsutani M. Aoki T, et al. Expert Opin Pharmacother. 2007 Dec;8(18):3133-46. doi: 10.1517/14656566.8.18.3133. Expert Opin Pharmacother. 2007. PMID: 18035958 Review.
• Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.

  Stuplich M, Hadizadeh DR, Kuchelmeister K, Scorzin J, Filss C, Langen KJ, Schäfer N, Mack F, Schüller H, Simon M, Glas M, Pietsch T, Urbach H, Herrlinger U. Stuplich M, et al. J Clin Oncol. 2012 Jul 20;30(21):e180-3. doi: 10.1200/JCO.2011.40.9565. Epub 2012 Jun 11. J Clin Oncol. 2012. PMID: 22689800 No abstract available.
• Adjuvant temozolomide: how long and how much?

  Franceschi E, Tosoni A, Brandes AA. Franceschi E, et al. Expert Rev Anticancer Ther. 2008 May;8(5):663-5. doi: 10.1586/14737140.8.5.663. Expert Rev Anticancer Ther. 2008. PMID: 18471038 No abstract available.
• [Standards and new developments in the chemotherapy of glioblastomas].

  Weller M. Weller M. Dtsch Med Wochenschr. 2005 Oct 7;130(40):2270-4. doi: 10.1055/s-2005-918562. Dtsch Med Wochenschr. 2005. PMID: 16208603 Review. German.